Related Experiment Video

Updated: Aug 8, 2026

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice

Estela P San-Emeterio1, María A Hurlé

  • 1Departamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Cantabria, Santander, Spain.

Neuroscience Letters
|May 24, 2006
PubMed

Insights

Naltrexone, an opioid antagonist, reduces pro-apoptotic proteins in the mouse brain. This suggests naltrexone offers neuroprotection against injuries involving mitochondrial or death receptor pathways.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Neuronal loss via apoptosis is a key feature in various neurological disorders.
  • Opioid antagonists like naloxone and naltrexone show potential neuroprotective effects in experimental and clinical settings.

Purpose of the Study:

  • To investigate the impact of naltrexone on proteins involved in extrinsic and mitochondrial apoptotic pathways in the mouse brain.
  • To assess the effect of naltrexone on the active fragment of caspase-3, an executioner of apoptosis.

Main Methods:

  • Mice were administered a single injection of naltrexone (1 mg/kg).
  • Western blotting was employed to analyze the expression levels of key apoptotic regulatory proteins.

Main Results:

  • Naltrexone significantly down-regulated the expression of pro-apoptotic proteins: Fas, FasL, Bad, and Bax.
  • The study focused on proteins regulating extrinsic (FasL, Fas) and mitochondrial (Bcl-2, Bcl-xL, Bad, Bax) apoptotic pathways.

Conclusions:

  • Naltrexone demonstrates neuroprotective capabilities by modulating apoptotic pathways.
  • These findings suggest naltrexone can shield neurons from damage mediated by both mitochondrial and death receptor-initiated apoptosis.

More Related Videos

A Conflict Model of Reward-seeking Behavior in Male Rats06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...